BALAXI PHARMACEUTICALS
Back to All Ratios
|
BALAXI PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| PCE(x) | 24.23 | 13.09 | -1,872.75 | 11.32 | 7.30 |
What is the latest Price to Cash Earnings (PCE) ratio of BALAXI PHARMACEUTICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2026 | 24.23 |
| Mar2025 | 13.09 |
| Mar2024 | -1,872.75 |
| Mar2023 | 11.32 |
| Mar2022 | 7.30 |
How is Price to Cash Earnings (PCE) of BALAXI PHARMACEUTICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2026 | 24.23 | 85.10 | |
| Mar2025 | 13.09 | Positive | |
| Mar2024 | -1872.75 | Negative | |
| Mar2023 | 11.32 | 55.07 | |
| Mar2022 | 7.3 | - | |
Other Financial Ratios of BALAXI PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹125.9 Cr | -3.8% | -6.8% | -53.3% | Stock Analytics | |
| ADANI ENTERPRISES | ₹403,409.0 Cr | -0.8% | -1.6% | 32.3% | Stock Analytics | |
| AEGIS LOGISTICS | ₹47,111.2 Cr | -1.9% | -0.5% | 104.2% | Stock Analytics | |
| PREMIER ENERGIES | ₹46,666.2 Cr | 1.3% | 0.9% | 5.5% | Stock Analytics | |
| ADITYA INFOTECH | ₹40,428.0 Cr | 2.3% | -3.3% | 218.6% | Stock Analytics | |
| REDINGTON | ₹28,538.7 Cr | 11.9% | 40.9% | 46% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -3.8% |
-6.8% |
-53.3% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses